FULC Operating Cash Flow (Statement)

Fulcrum Therapeutics Inc · Operating Cash Flow (Statement)

FULC logo

FULC Operating Cash Flow (Statement)

Latest reported-$65.78M
FULC TTM Cash from Operations (-$22.56M → -$65.78M)
High-resolution chart · PNG

FULC operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fulcrum Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-65,777,000
-63,558,000
-60,065,000
-60,028,000
-64,910,000
7,809,000
-2,218,000
-8,615,000
-12,449,000
-92,133,000
-90,965,000
-87,503,000
-92,479,000
-99,060,000
-97,050,000
-99,212,000
-93,903,000
-84,358,000
-78,478,000
-76,446,000
-58,377,000
-54,677,000
-53,655,000
-38,324,000
-46,837,000
-44,790,000
-39,483,000
-41,391,000
-32,494,000
-25,827,000
-22,562,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.